Yüklüyor......
Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia
PURPOSE: In contrast to the classic form, variant hairy cell leukemia (HCLv) responds poorly to single-agent purine analogs, expresses unmutated BRAF, has shorter overall survival, and lacks effective standard therapy. No treatment has achieved a high complete remission rate even in small series, an...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3867590/ https://ncbi.nlm.nih.gov/pubmed/24277451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1752 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|